Concurrent radiotherapy and weekly chemotherapy with low-dose cisplatin and 5-fluorouracil for ad-vanced cervical cancer
- VernacularTitle:低剂量顺铂联合5-氟尿嘧啶周疗同步放疗治疗中晚期宫颈癌
- Author:
Hui JIA
;
Zhaofeng ZHU
;
Peiying SU
- Publication Type:Journal Article
- Keywords:
Cervixneoplasms;
Combined modality therapy
- From:
Journal of International Oncology
2008;35(9):718-720
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the therapeutic efficiency and side effect of concurrent radiotherapy and weekly chemotherapy with low-dose eisplatin(DDP) and 5-fluorouracil(5-FU) for advanced cervical canc-er. Methods 73 patients with advanced cervical cancer were randomized into two groups: 37 cases in the chemo-radiotherapy group received radiotherapy combined with DDP 40 mg and 5-FU 500 mg weekly for 6-7 weeks. 36 cases in the only radiotherapy group received radiotherapy alone. Radiotherapy was given with conven-tional fraction,the total tumor dose was 50 Gy. Results The rate of overall response and three-year survival and local recurrenc and distant metastasis for the chemo-radiotherapy group and the only radiotherapy group were 97.30%, 89. 19%, 8. 11% and 10. 81%, and those for the only radiotherapy group were 77.78%,66. 67% ,30.56% and 33.33%. The difference of the four groups was statistically significant ( P <0. 05). The rate of bone marrow inhibition and reaction of digestive tract in chemo-radiotherapy group were higher than those in simple radiotherapy group, but most reactions were grade 1 and grade 2, without statistically significant dife-renee between two groups. Conclusion Concurrent radiotherapy and weekly chemotherapy with low-dose cis-platin and 5-fluorouracil for advanced cervical cancer can significantly improve local control rate and survival rate, and have slight side effects.
